Published guidance, NICE advice and quality standards | Guidance

Showing 471 to 480 of 1898

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Mental wellbeing at work	NG212	2 March 2022	2 March 2022
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies	TA772	23 February 2022	23 February 2022
PredictSURE IBD and IBDX to guide treatment of Crohn's disease	DG45	23 February 2022	23 February 2022
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules	DG46	23 February 2022	23 February 2022
Odevixibat for treating progressive familial intrahepatic cholestasis	HST17	22 February 2022	22 February 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer	TA770	9 February 2022	9 February 2022
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)	TA771	9 February 2022	9 February 2022
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)	TA762	2 February 2022	2 February 2022
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable	TA763	2 February 2022	2 February 2022
Fremanezumab for preventing migraine	TA764	2 February 2022	2 February 2022